We report the characterization of a series of oligothiophene-diketopyrrolopyrrole-fullerene triads and their use as active materials for solution processed organic solar cells (OSCs). By incorporating the diketopyrrolopyrrole (DPP) core with electron rich oligothiophene units and electron withdrawing fullerene units, multifunctional electronic molecules have been prepared; these molecules show high solubility in common organic solvents, excellent photophysical properties with high extinction coefficients (1 × 10(4) to 1 × 10(5) M(-1) cm(-1)) and broad absorption spectra coverage (250-800 nm), as well as suitable molecular orbital energy levels (HOMO of approximately -5.1 eV, LUMO of approximately -3.7 eV). Solution-processed thin-film organic field effect transistors (OFETs) from these triads revealed good n-type characteristics with electron mobilities up to 1.5 × 10(-3) cm(2) V(-1) s(-1). With these multifunctional triads, single-component OSCs have been fabricated, exhibiting power conversion efficiencies (PCEs) of up to 0.5 % under AM 1.5 G simulated 1 sun solar illumination. Blending these molecules with poly(3-hexylthiophene) (P3HT) afforded bulk heterojunction OSCs with PCEs reaching as high as 2.41%.
The photophysical properties of a thiophene-diketopyrrolopyrrole oligomer linked to two fullerene units via alkyl linkers of different lengths have been investigated in solution. The molecules exhibit excitation energy shuttling between the singlet and triplet photoexcited states. Photoexcitation of the oligomer is followed by singlet energy transfer to the fullerene, intersystem crossing to the triplet state, and then triplet energy transfer back to the oligomer. Competing electron transfer reactions, followed by recombination to the triplet state, are energetically possible and cannot be ruled out but were not observed and seem to have a small contribution in solution.
For many years researchers have understood the importance of the extracellular pH in solid tumors in relation to cancer morbidity and mortality. However current diagnostic imaging techniques do not allow for the non-invasive determination of pH in vivo. Recent research in the use of pH-responsive organic polymers for the preparation of imaging agents capable of imaging pH in vivo has demonstrated the tremendous potential of these materials in overcoming many of the problems associated with low molecular weight pH-responsive imaging agents. This review will highlight these recent developments with a focus on the use of pH-responsive polymers in the development of imaging agents for both fluorescent imaging and magnetic resonance spectroscopy and imaging.
Amphiphilic block copolymers were synthesized via a dual initiator chain transfer agent (inifer) that successfully initiated the ring opening polymerization (ROP) of L-lactide (LLA) and subsequently mediated the reversible addition-fragmentation chain transfer (RAFT) polymerization of poly(ethylene glycol) ethyl ether methacrylate (PEGEEMA). The formation of each polymer block was confirmed using 1 H nuclear magnetic resonance spectroscopy, as well as gel permeation chromatography, and comprehensive kinetics studies provide valuable insights into the factors influencing the synthesis of welldefined block copolymers. The effect of monomer concentration, reaction time, and molar ratios of inifer to catalyst on the ROP of LLA are discussed, as well as the ability to produce poly(lactide) blocks of different molecular weights. The synthesis of hydrophilic PPEGEEMA blocks was also monitored via kinetics to provide a better understanding of the role the chain transfer agent plays in facilitating the complex and sterically demanding RAFT polymerization of PEGEEMA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.